OBJECTIVE: To evaluate feasibility and safety of abdominal myomectomy with uterine myomas equal to or greater than 16 weeks in size. DESIGN: Retrospective chart review. SETTING: Private hospital. PATIENT(S): Women with uterine fibroids equal to or larger than 16 weeks in size. INTERVENTION(S): Abdominal myomectomy performed by one surgeon between March 1, 1998-February 28, 2003. MAIN OUTCOME MEASURE(S): Operating time, estimated blood loss, transfusion, cell-saver use, number and weight of fibroids removed, complications, pathology, and hospital stay were evaluated. RESULT(S): Ninety-one abdominal myomectomies met criteria. Mean operating time was 236 minutes (range, 120-390 minutes). Mean estimated blood loss was 794 mL (range, 50-3,000 mL). Seven (8%) women required homologous transfusion. Complications included one bowel injury, one bladder injury, one wound infection, and one reoperation for incarcerated small bowel. No woman had a uterine sarcoma or adenocarcinoma, and none required conversion to hysterectomy. CONCLUSION(S): Large uterine size does not preclude abdominal myomectomy and the results compare favorably with prior studies of hysterectomy for similar size uteri.
OBJECTIVE: To evaluate feasibility and safety of abdominal myomectomy with uterine myomas equal to or greater than 16 weeks in size. DESIGN: Retrospective chart review. SETTING: Private hospital. PATIENT(S): Women with uterine fibroids equal to or larger than 16 weeks in size. INTERVENTION(S): Abdominal myomectomy performed by one surgeon between March 1, 1998-February 28, 2003. MAIN OUTCOME MEASURE(S): Operating time, estimated blood loss, transfusion, cell-saver use, number and weight of fibroids removed, complications, pathology, and hospital stay were evaluated. RESULT(S): Ninety-one abdominal myomectomies met criteria. Mean operating time was 236 minutes (range, 120-390 minutes). Mean estimated blood loss was 794 mL (range, 50-3,000 mL). Seven (8%) women required homologous transfusion. Complications included one bowel injury, one bladder injury, one wound infection, and one reoperation for incarcerated small bowel. No woman had a uterine sarcoma or adenocarcinoma, and none required conversion to hysterectomy. CONCLUSION(S): Large uterine size does not preclude abdominal myomectomy and the results compare favorably with prior studies of hysterectomy for similar size uteri.
Authors: Katherine J Kramer; Sarah Ottum; Damla Gonullu; Capricia Bell; Hanna Ozbeki; Jay M Berman; Maurice-Andre Recanati Journal: PLoS One Date: 2021-12-09 Impact factor: 3.240
Authors: Elizabeth A Pritts; David J Vanness; Jonathan S Berek; William Parker; Ronald Feinberg; Jacqueline Feinberg; David L Olive Journal: Gynecol Surg Date: 2015-05-19